Deepika Pakianathan, Director at Alexza Pharmaceuticals Inc. (ALXA), bought 1,000 shares at $8.00 ($8K) on 2006-03-08, disclosed to the SEC on 2006-03-09.
Open-market purchase of $8k ALXA by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2024-06-04 | $1.4M | — | Filing → |
| CALA | SELL | 2023-01-31 | $47K | — | Filing → |
| KPTI | SELL | 2022-06-10 | $6.8M | — | Filing → |